ZINZINO AB (PUBL): PRELIMINARY SALES REPORT MAY 2023
GOTHENBURG, Sweden, June 5, 2023 /PRNewswire/ -- Zinzino group revenue increased with a total of 31 %, compared with the previous year.
The revenue in May for Zinzino's sales markets increased by 32 % and amounted to SEK 140.1 (106.0) million. Faun Pharma's external sales increased by 6 % and amounted to SEK 7.2 (6.8) million. Overall, the Group increased revenues by 31 % to SEK 147.3 (112.8) million compared with the previous year.
Accumulated revenue for January ? May 2023 increased by 21 % to SEK 662.3 (548.0) million.
Revenues were distributed as follows:
Regions,MSEK
23-May
22-May
Change
YTD 2023
YTD 2022
Change
The Nordics
25.7
26.9
-4 %
120.9
131.8
-8 %
Central Europe
34.2
20.5
67 %
154.4
99.4
55 %
East Europe
34.6
28.6
21 %
157.8
135.7
16 %
South & West Europe
25.0
12.2
105 %
89.5
61.3
46 %
The Baltics
7.5
6.0
25 %
35.6
29.4
21 %
North America
7.2
6.2
16 %
32.6
24.7
32 %
Asia-Pacific
4.5
5.0
-10 %
25.3
27.3
-7 %
Africa
1.4
0.6
133 %
6.2
2.5
148 %
Zinzino
140.1
106.0
32 %
622.3
512.1
22 %
Faun Pharma
7.2
6.8
6 %
40.0
35.9
11 %
Zinzino Group
147.3
112.8
31 %
662.3
548.0
21 %
Countries in regions:
The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA
Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
Africa: South Africa
For more information: Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Today, the Conference on Jewish Material Claims Against Germany (Claims Conference) launched a new digital campaign, #CancelHate. The campaign features Holocaust survivors reading Holocaust denial posts from across social media platforms. Each post...
With over four decades of nursing experience under her belt, Sherry Shaffer Ratajczak has witnessed firsthand the dedication of her colleagues in patient care. Yet, she observed a common misunderstanding: many are unaware of the extensive knowledge...
Today, a decision was issued by the Court of Appeals Division I in the State of Washington in Erickson v. Monsanto, ruling in Monsanto's favor on multiple grounds.
This decision reverses the initial verdict of $185 million in its entirety and...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Poseida Therapeutics, Inc. today announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos") and Poseida have entered into a...
Memorial Regional Hospital in Florida has earned the prestigious title of being the state's inaugural Resuscitation Center of Excellence (RCOE), underscoring the hospital's adherence to over 30 evidence-based criteria in providing top-tier cardiac...
Momcozy, a trusted global brand specializing in solution-focused maternal and baby care products since 2018, has announced their collaboration with 1 Natural Way (1NW), a nationally recognized Durable Medical Equipment company catering to the precise...